Management of Vasospastic Disorders with Botulinum Toxin A
@article{Beek2007ManagementOV, title={Management of Vasospastic Disorders with Botulinum Toxin A}, author={Allen L Van Beek and Paul K Lim and A. J. Gear and M. Pritzker}, journal={Plastic and Reconstructive Surgery}, year={2007}, volume={119}, pages={217-226} }
Background: Surgical digital artery sympathectomy is indicated when medical management has failed to control rest pain, impending infarction of digits, or healing of ischemic ulcerations caused by profound vasospasm that is associated with other systemic diseases. After digital artery sympathectomy, recurrence or persistence of vasospasm may compromise hand function and ultimately result in amputation of all or portions of both lower and upper extremities. Methods: The authors present a case… CONTINUE READING
Topics from this paper
Paper Mentions
Interventional Clinical Trial
Treating patients with Raynaud's phenomenon who have chronic pain and ulcerations is
extremely challenging. Published reports and our previous work support our hypothesis that… Expand
Conditions | Raynaud's Disease |
---|---|
Intervention | Drug |
Interventional Clinical Trial
Patients in the intensive care unit (ICU) often require blood pressure support of vasoactive
drugs such as amines. Finger necrosis (so called "blue toe syndrome") is a well documented… Expand
Conditions | Catocholamine Induced Finger Necrosis |
---|---|
Intervention | Drug |
112 Citations
Botulinum toxin type A: a treatment option for digital ischemia in patients with Raynaud's phenomenon.
- Medicine
- The Journal of hand surgery
- 2009
- 91
Botulinum toxin type A treatment for Raynaud’s phenomenon and other novel dermatologic therapeutic applications
- Medicine
- 2011
- 2
- PDF
Botulinum toxin for Raynaud's phenomenon: an useffull but seldom reminded therapy for severe cases
- 2019
- Highly Influenced
Recent advances for the management of Raynaud phenomenon using botulinum neurotoxin A.
- Medicine, Chemistry
- The Journal of hand surgery
- 2011
- 13
The Role of Botulinum Toxin A in the Treatment of Raynaud Phenomenon
- Medicine
- Annals of plastic surgery
- 2016
- 10
- Highly Influenced
Iatrogenic Thenar Eminence Atrophy After Botox A Injection for Secondary Raynaud Phenomenon.
- Medicine
- Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
- 2016
- 3
References
SHOWING 1-10 OF 29 REFERENCES
Adventitial stripping: a digit saving procedure in refractory Raynaud's phenomenon.
- Medicine
- The Journal of rheumatology
- 1998
- 46
Botulinum toxin in the treatment of Raynaud's phenomenon: a pilot study
- Medicine
- European journal of clinical investigation
- 2004
- 79
The use of digital artery sympathectomy as a salvage procedure for severe ischemia of Raynaud's disease and phenomenon.
- Medicine
- The Journal of hand surgery
- 1999
- 50
Acute and chronic ischemia of the hand: pathophysiology, treatment, and prognosis.
- Medicine
- The Journal of hand surgery
- 1991
- 56
Intravenous Iloprost Infusion in Patients with Raynaud Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Placebo-controlled, Double-Blind Study
- Medicine
- Annals of Internal Medicine
- 1994
- 346
Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma.
- Medicine
- The Journal of rheumatology
- 1999
- 52